CS logo
small CS logo
Hospital Fernando Fonseca

Amadora, Portugal
Government hospital in Amadora
IC19 276, 2720-276 Amadora

About Hospital Fernando Fonseca


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
10
European Organisation for Research and Treatment of Cancer - EORTC
3
MicroPort CRM
3
Bayer
2
Biogen
2
Celgene
2
Ferring Pharmaceuticals
2
Gilead Sciences
2
Pfizer
2
Abbott Medical Devices
1
Advanz Pharma
1
Total Rows: 25

Clinical Trials at Hospital Fernando Fonseca


During the past decade, Hospital Fernando Fonseca conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 17 clinical trials were completed, i.e. on average, 81% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years66333322441111110033003355331122Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fluorouracil With or Without Cisplatin in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
1997-05-01
Completed
200
Combination Chemotherapy in Treating Patients With Recurrent or Metastatic Colorectal Cancer
1998-03-01
Completed
554
Combination Chemotherapy in Treating Patients With Colorectal Cancer
2002-02-01
Completed
Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).
2002-12-01
2004-04-01
Completed
311
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
2006-05-01
2011-07-01
Completed
1,292
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
Study Evaluating The Efficacy And Safety Of Bapineuzumab In Alzheimer Disease Patients
2008-06-01
2013-08-01
Terminated
901
Study Evaluating the Safety and Efficacy of Bapineuzumab in Alzheimer Disease Patients
2008-01-01
2012-11-01
Terminated
1,100

Rows per page:

1–44 of 44

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Hospital Fernando Fonseca" #1 sponsor was "Boehringer Ingelheim" with 10 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials sponsored, "MicroPort CRM" with 3 trials sponsored, "Bayer" with 2 trials sponsored and "Biogen" with 2 trials sponsored. Other sponsors include 19 different institutions and companies that sponsored additional 25 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Fernando Fonseca" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "BeiGene" with 1 trials as a collaborator and "Sorin CRM" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 10Boehringer Ingelheim: 10European Organisationfor Research andTreatment of Cancer -EORTC: 3European Organisationfor Research andTreatment of Cancer -EORTC: 3MicroPort CRM: 3MicroPort CRM: 3Bayer: 2Bayer: 2Biogen: 2Biogen: 2Celgene: 2Celgene: 2Ferring Pharmaceuticals: 2Ferring Pharmaceuticals: 2Gilead Sciences: 2Gilead Sciences: 2Pfizer: 2Pfizer: 2Abbott Medical Devices: 1Abbott Medical Devices: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3Regeneron Pharmaceuticals: 2Regeneron Pharmaceuticals: 2BeiGene: 1BeiGene: 1Sorin CRM: 1Sorin CRM: 1

Clinical Trials Conditions at Hospital Fernando Fonseca


According to Clinical.Site data, the most researched conditions in "Hospital Fernando Fonseca" are "Alzheimer Disease" (4 trials), "Alzheimer's Disease" (2 trials), "Atrial Fibrillation" (2 trials), "Bradycardia" (2 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hospital Fernando Fonseca" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Fernando Fonseca


Most popular intervention types in "Hospital Fernando Fonseca" are "Drug" (35 trials), "Device" (8 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "Nintedanib" (3 trials), "fluorouracil" (3 trials), "BI 409306" (2 trials) and "Degarelix" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Fernando Fonseca


The vast majority of trials in "Hospital Fernando Fonseca" are 40 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Clinical Trials Status at Hospital Fernando Fonseca


Currently, there are NaN active trials in "Hospital Fernando Fonseca". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Hospital Fernando Fonseca, undefined suspended trials, and 9 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Fernando Fonseca, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 25Phase 3: 25Phase 2: 6Phase 2: 6Phase 4: 4Phase 4: 4Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 27Completed: 27Terminated: 9Terminated: 9Recruiting: 4Recruiting: 4Active, not recruiting: 2Active, not recruiting: 2Unknown status: 2Unknown status: 2